Price: 24.50 EUR
Graviola whole leaf liquid extract.
The tincture has a potent antioxidant effect. It stimulates the immune system and protects the body from infections. The product promotes the body’s natural defence mechanisms against viruses, bacteria and fungi. It has a beneficial effect on the functions of the neural system, promotes sound sleep and helps maintain the normal blood pressure levels.
Many bioactive compounds and phytochemicals have been found in graviola, as scientists have been studying its properties since the 1940s. Its many uses in natural medicine have been validated by scientific research. Several studies by different researchers demonstrated that the bark as well as the leaves had hypotensive, antispasmodic, anticonvulsant, vasodilator, smoothmuscle relaxant, and cardiodepressant activities in animals. Several studies over the years have demonstrated that leaf, bark, root, stem, and seed extracts of graviola are antibacterial in vitro against numerous pathogens,and that the bark has antifungal properties. Graviola seeds demonstrated active antiparasitic properties in a 1991 study, and a leaf extract showed to be active against malaria in two other studies (in 1990 and 1993). The leaves, root, and seeds of graviola demonstrated insecticidal properties, with the seeds demonstrating strong insecticidal activity in an early 1940 study. In a 1997 clinical study, novel alkaloids found in graviola fruit exhibited antidepressive effects in animals.
In 1997, Purdue University published information with promising news that several of the Annonaceous acetogenins “… not only are effective in killing tumors that have proven resistant to anti-cancer agents, but also seem to have a special affinity for such resistant cells.” In several interviews after this information was publicized, the head pharmacologist in Purdue’s research explained how this worked. As he explains it, cancer cells that survive chemotherapy can develop resistance to the agent originally used as well as to other, even unrelated, drugs. This phenomenon is called multi-drug resistance (MDR). One of the ways that cancer cells develop resistance to chemotherapy drugs is by creating an intercellular efflux pump called a P-glycoprotein mediated pump. These types of pumps are capable of pushing anticancer agents out of the cell before they can kill it. On average, only about two percent of the cancer cells in any given person might develop this pump – but they are the two percent that can eventually grow and expand to create multi-drug resistant tumors. Some of the latest research on acetogenins reported that they were capable of shutting down these intercellular pumps, thereby killing MDR tumors. Purdue researchers reported that the acetogenins preferentially killed multi-drug-resistant cancer cells by blocking the transfer of ATP – the chief source of cellular energy – into them. A tumor cell needs energy to grow and reproduce, and a great deal more to run its pump and expel attacking agents. By inhibiting energy to the cell, it can no longer run its pump. When acetogenins block ATP to the tumor cell over time, the cell no longer has enough energy to operate sustaining processes – and it dies.
Read carefully the directions on the label or product leaflet before use.